Topic: Staff

Podcast
6 podcasts
Seminar
3 seminars
Grant
1 grant

Domains featuring this topic

Explore the domains where this topic appears.

SeminarNeuroscience

Emerging NeuroTech: Ultrasound in Neuroscience

Massachusetts Institute of Technology
Aug 14, 2026

Two talks present emerging applications of ultrasound technology in neuroscience, spanning brain imaging and human-machine interaction. The in-person seminar is open to MIT researchers, students, and staff and is supported by the MIT School of Science and the Feng Lab at the McGovern Institute.

PodcastNeuroscience

Briefing Chat: Is DNA repair the secret to a long life?

Aug 7, 2026

Nature staff discuss evidence from whales and mole rats suggesting that DNA repair may contribute to longevity, and how COVID-19 can reactivate dormant viruses.

PodcastPodcasts

Briefing Chat: Orcas smashed a sunfish to bits — researchers aren’t sure why

Jul 31, 2026

Nature staff discuss a large survey of insect diversity in the Amazon and unusual orca behavior captured on video involving a sunfish.

PodcastNeuroscience

Briefing Chat: Baby T. rex were killers from birth, suggest new fossils

Jul 24, 2026

Nature staff discuss evidence that young tyrannosaurs hunted from birth, the weapons used by ancient Egyptian princesses and London’s emerging role in artificial-intelligence safety.

PodcastNeuroscience

Briefing Chat: Sweet! Elusive sugar molecules found in space

Jul 17, 2026

Nature staff discuss the discovery of a four-carbon sugar molecule in interstellar space and a newly decoded formula that identifies a Maya mathematician.

PodcastGenetics

Briefing Chat: The 30 year-legacy of a science icon — Dolly the sheep

Jul 10, 2026

Nature staff revisit the landmark cloning of Dolly the sheep from an adult cell and discuss the first direct observation of ocean-floor crust being created.

PodcastEthology

Briefing Chat: What tickling a chimpanzee can tell us about the evolution of speech

Jun 26, 2026

Nature staff discuss rhythmic laughter in apes, what it may reveal about the evolution of speech, and evidence that AI use can erode skills in medicine and computing.

SeminarNeuroscience

NeurotechEU Summit

Ms Vanessa Debiais Sainton, Prof. Staffan Holmin, Dr Mohsen Kaboli and Prof. Peter Hagoort
European Commission, Karolinska Institutet, BMW Group, Max Planck Institute for Psycholinguistics and Donders Institute
Nov 22, 2021

Our first NeurotechEU Summit will be fully digital and will take place on November 22th from 09:00 to 17:00 (CET). The final programme can be downloaded here. Hosted by the Karolinska Institutet, the summit will provide you an overview of our actions and achievements from the last year and introduce the priorities for the next year. You will also have the opportunity to attend the finals of the 3 minute thesis competition (3MT) organized by the Synapses Student Society, the student charter of NeurotechEU. Good luck to all the finalists: Lynn Le, Robin Noordhof, Adriana Gea González, Juan Carranza Valencia, Lea van Husen, Guoming (Tony) Man, Lilly Pitshaporn Leelaarporn, Cemre Su, Kaya Keleş, Ramazan Tarık Türksoy, Cristiana Tisca, Sara Bandiera, Irina Maria Vlad, Iulia Vadan, Borbála László, and David Papp! Don’t miss our keynote lecture, success stories and interactive discussions with Ms Vanessa Debiais Sainton (Head of Higher Education Unit, European Commission), Prof. Staffan Holmin (Karolinska Institutet), Dr Mohsen Kaboli (BMW Group, member of the NeurotechEU Associates Advisory Committee), and Prof. Peter Hagoort (Max Planck Institute for Psycholinguistics, Donders Institute). Would you like to use this opportunity to network? Please join our informal breakout sessions on Wonder.me at 11:40 CET. You will be able to move from one discussion group to another within 3 sessions: NeurotechEU ecosystem - The Associates Advisory Committee: Synergies in cross-sectoral initiatives Education next: Trans-European education and the European Universities Initiatives - Lessons learned thus far. Equality, diversity and inclusion at NeurotechEU: removing access barriers to education and developing a working, learning, and social environment where everyone is respected and valued. You can register for this free event at www.crowdcast.io/e/neurotecheu-summit

SeminarMedicine

Hughlings Jackson Lecture: Making Progress in Progressive MS – the Ultimate Challenge!

Alan Thompson
niversity College London and the UCL Institute of Neurology, London, UK
Apr 22, 2021

On April 22, 2021, Dr. Alan J Thompson of the University College London and the UCL Institute of Neurology, London, UK will deliver the Hughlings Jackson Lecture entitled, “Making Progress in Progressive MS – the Ultimate Challenge!” Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honors the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty. Talk Abstract : The international focus on progressive MS, driven by the Progressive MS Alliance amongst others, together with recent encouraging results from clinical trials have raised the profile and emphasised the importance of understanding, treating and ultimately preventing progression in MS. Effective treatment for Progressive MS is now regarded as the single most important issue facing the MS community. There are several important challenges to developing new treatments for progressive MS. Fundamental to any development in treatment is a better understanding of the mechanisms of tissue injury underpinning progression which will in turn allow the identification of new targets against which treatments can be directed. There are additional complications in determining when progression actually starts, determining the impact of aging and defining the progressive clinical phenotypes – an area which has become increasingly complex in recent months. Evaluating potential new treatments in progressive MS also poses particular challenges including trial design and the selection of appropriate clinical and imaging outcomes - in particular, identifying an imaging biomarker for phase II trials of progressive MS. Despite these challenges, considerable progress is being made in developing new treatments targeting the innate immune system and exploring neuroprotective strategies. Further advances are being driven by a number of international networks, funded by the Progressive MS Alliance. Overall we are seeing encouraging progress as a result of co-ordinated global collaboration which offers real possibilities for truly effective treatment of progression.

Grant

Individual Research Grants

Deutsche Forschungsgemeinschaft (DFG)

DFG's central individual funding programme for research projects in all disciplines: 'The first proposal may be submitted at any time.' Duration is based on individual project needs, as a rule several years, with modules for staff, instrumentation and other project costs.

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.